These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 16814328)

  • 1. Chromosome aberrations in solid tumors have a stochastic nature.
    Castro MA; Onsten TG; Moreira JC; de Almeida RM
    Mutat Res; 2006 Aug; 600(1-2):150-64. PubMed ID: 16814328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profiling cytogenetic diversity with entropy-based karyotypic analysis.
    Castro MA; Onsten TT; de Almeida RM; Moreira JC
    J Theor Biol; 2005 Jun; 234(4):487-95. PubMed ID: 15808870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stochastic cancer progression driven by non-clonal chromosome aberrations.
    Heng HH; Stevens JB; Liu G; Bremer SW; Ye KJ; Reddy PV; Wu GS; Wang YA; Tainsky MA; Ye CJ
    J Cell Physiol; 2006 Aug; 208(2):461-72. PubMed ID: 16688757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of cytogenetic methods to analysis of etiologic factors in carcinogenesis.
    Mitelman F
    IARC Sci Publ; 1982; (39):481-96. PubMed ID: 6759387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Power law distribution of chromosome aberrations in cancer.
    Frigyesi A; Gisselsson D; Mitelman F; Höglund M
    Cancer Res; 2003 Nov; 63(21):7094-7. PubMed ID: 14612501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosome abnormalities as primary events in human malignant disease: evidence from marker chromosomes.
    Atkin NB; Baker MC
    J Natl Cancer Inst; 1966 Mar; 36(3):539-57. PubMed ID: 18630328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer progression by non-clonal chromosome aberrations.
    Heng HH; Bremer SW; Stevens J; Ye KJ; Miller F; Liu G; Ye CJ
    J Cell Biochem; 2006 Aug; 98(6):1424-35. PubMed ID: 16676347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SKY analysis of childhood neural tumors and cell lines demonstrates a susceptibility of aberrant chromosomes to further rearrangements.
    Stanchescu R; Betts DR; Yekutieli D; Ambros P; Cohen N; Rechavi G; Amariglio N; Trakhtenbrot L
    Cancer Lett; 2007 May; 250(1):47-52. PubMed ID: 17084022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statistical behavior of complex cancer karyotypes.
    Höglund M; Frigyesi A; Säll T; Gisselsson D; Mitelman F
    Genes Chromosomes Cancer; 2005 Apr; 42(4):327-41. PubMed ID: 15645488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telomere length heterogeneity and chromosome instability.
    Londoño-Vallejo JA
    Cancer Lett; 2004 Aug; 212(2):135-44. PubMed ID: 15341022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytogenetic evaluation of childhood neoplasms.
    Schneider NR
    Arch Pathol Lab Med; 1993 Dec; 117(12):1220-4. PubMed ID: 8250692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple numerical chromosome aberrations in cancer: what are their causes and what are their consequences?
    Teixeira MR; Heim S
    Semin Cancer Biol; 2005 Feb; 15(1):3-12. PubMed ID: 15613283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fusion genes and rearranged genes as a linear function of chromosome aberrations in cancer.
    Mitelman F; Johansson B; Mertens F
    Nat Genet; 2004 Apr; 36(4):331-4. PubMed ID: 15054488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The karyotypic structure of cell populations in vitro as an integral system.
    Polianskaya GG; Vakhtin IuB
    Tsitologiia; 2003; 45(2):115-31. PubMed ID: 12722476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytogenetic analysis of 101 giant cell tumors of bone: nonrandom patterns of telomeric associations and other structural aberrations.
    Gorunova L; Vult von Steyern F; Storlazzi CT; Bjerkehagen B; Follerås G; Heim S; Mandahl N; Mertens F
    Genes Chromosomes Cancer; 2009 Jul; 48(7):583-602. PubMed ID: 19396867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonal and non-clonal chromosome aberrations and genome variation and aberration.
    Heng HH; Liu G; Bremer S; Ye KJ; Stevens J; Ye CJ
    Genome; 2006 Mar; 49(3):195-204. PubMed ID: 16604101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence estimates of recurrent balanced cytogenetic aberrations and gene fusions in unselected patients with neoplastic disorders.
    Mitelman F; Mertens F; Johansson B
    Genes Chromosomes Cancer; 2005 Aug; 43(4):350-66. PubMed ID: 15880352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosome alterations associated with positive and negative lymph node involvement in breast cancer.
    Wuicik L; Cavalli LR; Cornélio DA; Schmid Braz AT; Barbosa ML; Lima RS; Urban CA; Bleggi Torres LF; Ribeiro EM; Cavalli IJ
    Cancer Genet Cytogenet; 2007 Mar; 173(2):114-21. PubMed ID: 17321326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosomal abnormalities of adenocarcinoma of the pancreas: identifying early and late changes.
    Kowalski J; Morsberger LA; Blackford A; Hawkins A; Yeo CJ; Hruban RH; Griffin CA
    Cancer Genet Cytogenet; 2007 Oct; 178(1):26-35. PubMed ID: 17889705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and cytogenetic analyses in uveal melanoma.
    Kilic E; van Gils W; Lodder E; Beverloo HB; van Til ME; Mooy CM; Paridaens D; de Klein A; Luyten GP
    Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3703-7. PubMed ID: 16936076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.